In this review, we summarise recently discovered potential biomarkers to improve the diagnosis of, and prognosis for ovarian cancer, and revisit the clinically available biomarkers and their …

Dec 1, 2020 · Early detection of ovarian cancer remains an important unmet medical need. Effective screening could reduce mortality by 10%–30%. Used individually, neither serum …

Oct 14, 2022 · Here, we report on these findings and their potential for use in future clinical trial design on the basis of hierarchal evidence grading. The biomarkers were classified on the …

Feb 29, 2024 · This article aims to provide an up-to-date review of potential biomarkers for screening and early diagnosis of OC which may have the potential to transform its diagnostic …

Mar 27, 2019 · Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms. Serum CA125 assay has low …

Novel markers like microRNAs, DNA methylation patterns, and circulating tumor cells offer potential for enhanced diagnostic accuracy and personalized management. Integrating these …

Dec 5, 2019 · HE4 is a prospective single serum biomarker which has been approved by the FDA to monitor the disease progression in epithelial ovarian cancer. However, owing to low …

Nov 17, 2021 · In this review, we summarize the recent advances and perspectives in the use of multi-omics technologies in OC research and highlight potential applications of multi-omics for …

Dec 3, 2019 · Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has begun to provide clinically …

Mar 7, 2021 · The capacity of these biomarkers to predict the existence, stages, and associated therapeutic efficacy of ovarian cancer would enable improvements in the early diagnosis and …